AIとIPFと癒しの音楽

特発性肺線維症 idiopathic pulmonary fibrosis (IPF)患者によるIPF関連学術情報の収集とシェア。癒しの音楽もお届けしています。

IPF Weekly Update

<><><>

23/04/14

 

[HTML] A novel corpus of molecular to higher-order events that facilitates the understanding of the pathogenic mechanisms of idiopathic pulmonary fibrosis

N Nagano, N Tokunaga, M Ikeda, H Inoura, DA Khoa… - Scientific Reports, 2023

Idiopathic pulmonary fibrosis (IPF) is a severe and progressive chronic fibrosing 

interstitial lung disease with causes that have remained … pathogenetic 

mechanisms of IPF at both the molecular and cellular levels. With a biomedical …

  • 特発性肺線維症の発症メカニズムの理解を促進する、分子レベルから高次レベルのイベントの新規コーパス 



[HTML] 5-methyladenosine regulators play a crucial role in development of chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis

Y Zhou, Z Hu, Q Sun, Y Dong - Scientific Reports, 2023

… pneumonitis (CHP) and idiopathic pulmonary fibrosis (IPF) remains unknown. 

Expression … and nomogram models to predict risks of pulmonary fibrosis. Next, we 

applied the consensus … and plays a crucial role in development of pulmonary

  • 5-メチルアデノシン調節因子は、慢性過敏性肺炎および特発性肺線維症の発症に重要な役割を果たす 



Idiopathic Pulmonary Fibrosis and the Many Faces of UIP

F Luppi, L Richeldi - Orphan Lung Diseases: A Clinical Guide to Rare Lung …, 2023

… belongs to the group of idiopathic interstitial cases of pneumonia (IIPs) [1]. In this 

group, idiopathic pulmonary fibrosis (IPF) is the most … Particularly, a number of 

these disorders show usual interstitial pneumonia (UIP) pattern, suggesting that UIP …

  • 特発性肺線維症とUIPの多面性 



Lifestyle, Genetic Susceptibility, and the Risk of Idiopathic Pulmonary Fibrosis: A large Prospective Cohort Study

Y Ma, F Cui, D Li, J Wang, L Tang, J Xie, Y Hu, Y Tian - Chest, 2023

idiopathic interstitial pneumonia, idiopathic 36 pulmonary fibrosis (IPF) is a 

chronic, heterogeneous, irreversible progressive fibrotic 37 lung disease[1]. Given 

the unknown etiology of IPF and the lack of targeted treatment 38 strategies, IPF … a …

  • ライフスタイル、遺伝的感受性、および特発性肺線維症のリスク:大規模な前向きコホート研究 



Gastroesophageal Reflux: Idiopathic Pulmonary Fibrosis and Lung Transplantation

C Scallan, G Raghu - Orphan Lung Diseases: A Clinical Guide to Rare Lung …, 2023

Many co-morbidities have been identified in patients with idiopathic pulmonary 

fibrosis (IPF) and there is growing interest in their impact on disease pathogenesis 

and outcomes. The importance of the relationship between the upper GI tract and …

  • 胃食道逆流:特発性肺線維症と肺移植 



[HTML] Inescapable Fibrosis: The Development of Desquamative Interstitial Pneumonia Post-Lung Transplantation Performed for a Patient with Idiopathic Pulmonary Fibrosis

P Lilburn, D Pillutla, V Sivasubramaniam, M Plit - Case Reports in Transplantation, 2023

progressive hypoxaemic respiratory failure from idiopathic pulmonary fibrosis

Three years later, … the recurrence of usual interstitial pneumonia/idiopathic 

pulmonary fibrosis; rather, two separate … In this report, we describe a case of a …

  • 避けられない線維症: 特発性肺線維症患者のために行われた肺移植後の落屑性間質性肺炎の発症 



Imaging of Pulmonary Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis

KS Lee, J Han, N Wada, A Hata, HY Lee, CA Yi, T Hino… - American Journal of …, 2023

Idiopathic pulmonary fibrosis (IPF), corresponding histologically with usual 

interstitial pneumonia and representing the most common idiopathicProgressive 

pulmonary fibrosis (PPF) describes the radiologic development of pulmonary fibrosis

  • 肺線維症のイメージング: 更新、線維症のイメージングに関する AJR スペシャル シリーズから 



[HTML] Short Telomere Syndrome presenting with pulmonary fibrosis, liver cirrhosis and hepatopulmonary syndrome: a case report

A Baird, M Gomes, CA Souza, K Magner, G Alvarez - BMC Pulmonary Medicine, 2023

Idiopathic pulmonary fibrosis is thought to result from aberrant post-injury 

activation of epithelial cells leading to fibroblast proliferation and activation. A 

number of genetic aetiologies have been implicated in this disease process …

  • 肺線維症、肝硬変および肝肺症候群を呈する短いテロメア症候群:症例報告  



[PDF] Demystifying the Enigmatic Fibroblast in Pulmonary Fibrosis

Y Zhou, VJ Thannickal - American Journal of Respiratory Cell and Molecular …, 2023

… While fibroblast phenotype and function have received significant attention as 

effector cells in lung diseases such as idiopathic pulmonary fibrosis (IPF), relatively 

less attention has focused on their physiological and pro-regenerative roles (2, 3). A …

  • 肺線維症における謎の線維芽細胞の解明




23/04/13

 

[PDF] Pulmonary Fibrosis and Antioxidants: Finding the Right Target

LP Diebold, M Jain - American Journal of Respiratory Cell and Molecular …, 2023

idiopathic pulmonary fibrosis (IPF), a severe form of fibrosing ILD, is fatal, having 

a median survival of only 3-5 years (3). Currently, therapeutic options for IPF … 

While there is an incomplete understanding of the molecular mechanisms that lead …

  • 肺線維症と抗酸化物質:正しい標的を見つける

 

23/04/11

 

[HTML] Biomarkers of cellular senescence in idiopathic pulmonary fibrosis

Z Aversa, EJ Atkinson, EM Carmona, TA White… - Respiratory Research, 2023

… stress that has been implicated in the pathogenesis of idiopathic pulmonary 

fibrosis (IPF). The associations between circulating levels of … studied in IPF. In this 

study we assessed the circulating levels of candidate senescence biomarkers in …

  • 特発性肺線維症における細胞老化のバイオマーカー 



[HTML] Role of pulmonary function tests and computed tomography volumetric quantitative analysis in assessment of idiopathic pulmonary fibrosis

OM Zaki, RS Sharshar, RL Younes, AM AbdElla - The Egyptian Journal of Chest …, 2023

… Background Idiopathic pulmonary fibrosis (IPF) is a progressive irreversible lung 

disease, but early assessment by pulmonary … with IPF. Objectives The study 

aimed to study the role of quantitative volumetric CT indices and PFTs in assessing …

  • 特発性肺線維症の評価における肺機能検査とCT容積定量分析の役割  



[PDF] The function of S100A4 in pulmonary disease: A review

T Wang - Medicine, 2023

… Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of 

current and future … Pharmacotherapy and adjunctive treatment for idiopathic 

pulmonary fibrosis (IPF). J Thorac … in the lungs of patients with idiopathic

  • 肺疾患におけるS100A4の機能:レビュー  



[HTML] Acute exacerbation of pleuroparenchymal fibroelastosis with lower lobe usual interstitial pneumonia: An autopsy case

T Matsumura, T Makino, M Yagisawa, M Ishige… - Respiratory Medicine Case …, 2023

… This histopathology pattern was considered probable UIP according to the 

idiopathic pulmonary fibrosis (IPF) clinical practice guidelines [7… In summary, the 

autopsy demonstrated that the patient had idiopathic PPFE in the upper lobe and …

  • 下葉通常間質性肺炎を伴う胸膜実質線維弾性症の急性増悪:剖検例  



[HTML] Collagen type I alters the proteomic signature of macrophages in a collagen morphology-dependent manner

GF Vasse, S Russo, A Barcaru, AAA Oun, AM Dolga… - Scientific Reports, 2023

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease with 

a short life expectancy of 2–3 years after diagnosis. … For example, fibrils of 

collagen type I, the most abundant ECM protein in fibrosis, are structurally different …

  • I型コラーゲンはマクロファージのプロテオミクス特性をコラーゲンの形態依存的に変化  



[PDF] Identifying phenotypes in interstitial lung disease using group-based trajectory modelling

S Takata, S Komukai, T Hoshino, H Tabuchi… - The International Journal of …, 2023

… Interstitial lung disease (ILD) is a heterogeneous condition caused by several 

distinct diseases, including idiopathic pulmonary fibrosis (IPF), connective tissue 

disease-associated ILD (CTD-ILD), interstitial pneumonia with autoimmune features …

  • グループベースの軌跡モデリングを使用した間質性肺疾患の表現型の特定   



[HTML] Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?

G Tikellis, T Corte, IN Glaspole, N Goh, YH Khor… - BMC Pulmonary Medicine, 2023

… 47% had idiopathic pulmonary fibrosis or connective tissue disease-associated 

ILD, 62% were female and the average age was 66 years. Whilst 56% rated their 

overall health in 2020 as the same as months prior, 38% indicated a worsening in …

  • COVID-19 パンデミック時の ILD 患者の遠隔医療体験を理解する: 私たちは何を学んだか?   



23/04/08

 

ROS-activatable nanocomposites for CT imaging tracking and antioxidative protection of mesenchymal stem cells in idiopathic pulmonary fibrosis therapy

Y Lv, C Yu, X Li, H Bao, S Song, X Cao, H Lin, J Huang… - Journal of Controlled …, 2023

… a promising approach in the treatment of idiopathic pulmonary fibrosis (IPF), while 

it is still … of the transplanted MSCs for 21 days in IPF treatment, obtaining the 

location and distribution … NPs, thereby enhancing the therapeutic efficacy against …

  • 特発性肺線維症治療におけるCTイメージング追跡および間葉系幹細胞の抗酸化保護のためのROS活性化ナノコンポジット  



[PDF] Idiopathic Pulmonary Fibrosis (IPF), a general overview

E Cocconcelli - … course in patients with Idiopathic Pulmonary Fibrosis

idiopathic pulmonary fibrosis65. Additionally, CTGF in plasma was reported to be 

elevated in patients with idiopathic pulmonary fibrosis and … Gastro-oesophageal 

reflux and idiopathic pulmonary fibrosis: The heart burn in patients with IPF can no …

  • 特発性肺線維症(IPF)の概要  



[PDF] New Guidelines for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

H Yoo - The Korean Journal of Medicine, 2023

Idiopathic pulmonary fibrosis (IPF) is the most common and fatal idiopathic 

interstitial pneumonia and is characterized by chronic progressive pulmonary 

fibrosis … Thoracic Society published joint clinical practice guidelines for IPF. The …





[PDF] Exploring key genes and mechanisms associated with idiopathic pulmonary fibrosis and lung adenocarcinoma

S Huang, X Wu, Y Sun, Z Xu, X Zhang - 2023

Idiopathic pulmonary brosis (IPF) is a speci c type of ILD that is characterized by 

progressive and chronic … IPF and LUAD that makes it possible for IPF to cause 

cancer[8, 9]. Given the poor prognosis and unpredictable course of IPF, further …

  • 特発性肺線維症と肺腺癌に関連する重要な遺伝子とメカニズムの探索    




[PDF] Progressive pulmonary fibrosis (PPF), a new clinical entity

E Cocconcelli - … course in patients with Idiopathic Pulmonary Fibrosis

… with ILD other than IPF, presenting a clinical course similar to IPF despite a good 

adherence … IPF is the most common among the idiopathic interstitial pneumonia 

and presents a clinical/… clinical practice guideline: Treatment of idiopathic

  • 進行性肺線維症 (PPF)、新しい臨床実体   



[HTML] Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression

R Inoue, T Yasuma, V Fridman D'Alessandro, M Toda… - International Journal of …, 2023

Idiopathic interstitial pneumonias are the main subgroup of ILD, representing 

about 40%, and of these, a subgroup classified as idiopathic pulmonary fibrosis (IPF

is the most common form, accounting for more than half of idiopathic interstitial …

  • マトリックスメタロプロテイナーゼ-2の過剰発現による肺線維症の改善  



[HTML] Perspective for Studying the Relationship of miRNAs with Transposable Elements

RN Mustafin, E Khusnutdinova - Current Issues in Molecular Biology, 2023

… Aging increases the risk of developing idiopathic pulmonary fibrosis from 4 per 

100,000, for people aged 18–34, to 227.2 per 100,000, for people 75 and older. The 

average age of idiopathic pulmonary fibrosis patients is 66 years [64]. Survival with …

  •  miRNA と転移因子との関係を研究するための展望



<><><>

特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。

当面、毎週アラートの内容をアップしていこうと思います。

 

癒しの音楽をお届けいたします。 

youtu.be

###